Convertible,Reversible,/methenamine1250211.html,with,HONBAY,Sectional,$629,Home Kitchen , Furniture , Living Room Furniture , Living Room Sets,new.meri.edu.in,Sofa,Modular,Couch $629 HONBAY Convertible Sectional Couch Modular Sofa with Reversible Home Kitchen Furniture Living Room Furniture Living Room Sets Convertible,Reversible,/methenamine1250211.html,with,HONBAY,Sectional,$629,Home Kitchen , Furniture , Living Room Furniture , Living Room Sets,new.meri.edu.in,Sofa,Modular,Couch HONBAY Convertible Sectional Couch Superior Reversible with Sofa Modular HONBAY Convertible Sectional Couch Superior Reversible with Sofa Modular $629 HONBAY Convertible Sectional Couch Modular Sofa with Reversible Home Kitchen Furniture Living Room Furniture Living Room Sets

HONBAY Convertible Sectional Couch Superior Reversible Cheap sale with Sofa Modular

HONBAY Convertible Sectional Couch Modular Sofa with Reversible

$629

HONBAY Convertible Sectional Couch Modular Sofa with Reversible

|||

Product Description

modular sofamodular sofa

Free Combination —— HONBAY Modulac Sofa

sofa setsofa set

Note:

  • Delivery Time: It need 5-10 business day to ship 5 packages of sectional sofa, maybe 5 packages won't arrive at the same time, please patiently wait for 3-5 business days.
  • Just tell us if you have any issues about our item - HONBAY Customers' Services Team
armchair sofa sectional sofa L shape sofa U sofa sectional sofa
Armchair 3-Seater Couch Sectional with Ottoman 4-Seater Couch U-Shaped Sofa Sectional Sofa
Color Aqua Blue Grey Bluish Grey Brown Aqua Blue Dark Khaki
Fabric Polyester Polyester Linen Brown Polyester Suede
Type Modular Modular Sectional Sectional Modular Sectional

HONBAY Convertible Sectional Couch Modular Sofa with Reversible

Selleck製品は、NatureやScience等の権威ある科学雑誌に掲載された論文中で数多く使用されています。

Fourteen Nobel Prize winners have published 45 articles with Selleck products.

THE NOBEL PRIZE

David Julius

Won the Nobel Prize in Physiology or Medicine in 2021

Michael Houghton

Won the Nobel Prize in Physiology or Medicine in 2020

Brian K. Kobilka

Won the Nobel Prize in Chemistry in 2012

Robert Lefkowitz

Won the Nobel Prize in Chemistry in 2012

Aaron Ciechanover

Won the Nobel Prize in Chemistry in 2004

新製品

製品コード 製品名 Target Pathway 製品説明
S8944 G150 Others Others G150 is a potent and highly selective human cyclic GMP-AMP synthase (h-cGAS) inhibitor with IC50 of 10.2 nM.
S8913 TH5487 Others Others TH5487 is a selective active-site inhibitor of 8-oxoguanine DNA glycosylase 1 (OGG1) with IC50 of 342 nM.
S8938 KGA-2727 SGLT GPCR & G Protein KGA-2727 is a potent, selective, high-affinity inhibitor of sodium glucose cotransporter 1 (SGLT1) with Ki of 97.4 nM and 43.5 nM for human SGLT1 and rat SGLT1, respectively. The selectivity ratios (Ki for SGLT2/Ki for SGLT1) of KGA-2727 are 140 (human) and 390 (rat). KGA-2727 exhibits antidiabetic efficacy in rodent models.
S8939 Mizagliflozin SGLT GPCR & G Protein Mizagliflozin is a novel, potent, selective sodium glucose co-transporter 1 (SGLT1) inhibitor with Ki of 27 nM for human SGLT1. The selectivity ratio (Ki value for human SGLT2/Ki value for human SGLT1) of mizagliflozin is 303. Mizagliflozin shows the potential use for the amelioration of chronic constipation.
S7013 Guadecitabine (SGI-110) Others Others Guadecitabine (SGI-110) is a next-generation hypomethylating agent whose active metabolite decitabine has a longer in-vivo exposure time than intravenous decitabine.
S8812 CM272 DNA Methyltransferase Epigenetics CM-272 is a novel first-in-class dual reversible inhibitor of G9a (GLP) and DNMTs with IC50 of 8 nM, 382 nM, 85 nM, 1200 nM, 2 nM for G9a, DNMT1, DNMT3A, DNMT3B, GLP, respectively. CM-272 prolongs survival in in vivo models of haematological malignancies by at least in part inducing immunogenic cell death.
S9729 Visomitin (SKQ1) Others Others INT-777 (S-EMCA) is a novel potent and selective TGR5 agonist with EC50 values of 0.18 μM, 3.9 μM and 1.45 μM for WT TGR5, TGR5(N76A) and TGR5(Y89F) respectively.
S8500 BAY1125976 Akt PI3K/Akt/mTOR BAY 1125976 is a selective allosteric AKT1/2 inhibitor,exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models. BAY1125976 inhibits the activity of AKT1 (IC50 = 5.2 nM at 10 µM ATP and 44 nM at 2 mM ATP) and AKT2 (IC50 = 18 nM at 10 µM ATP and 36 nM at 2 mM ATP) very potently.Whereas BAY1125976 is almost inactive on AKT3 (IC50 = 427 nM at 10 µM ATP).